Hints and tips:
...V. Group, the world’s largest ship manager, has urged Nato to provide naval escorts for commercial ships....
...Equity selling mostly came from HF& systematic investors, but LO de-risking was less aggressive, in particular compared to Credit....
...The author of The Selfish Gene will be leading an 11-day group trip to the Galápagos, touring seven islands and staying onboard the M/V Evolution....
...We’re also opening negotiations on a city deal with Edinburgh; we back the new V&A in Dundee....
...One of the group read “Canto V”, the tale of Paolo and Francesca, who whirl eternally in each other’s arms through swirling gusts....
...The transaction was financed by Deutsche Bank, which in 2008 renegotiated more than €3bn in debts with Actavis and remains a creditor. Actavis was set to be auctioned in 2009....
...A Reuters report said the company was in talks to buy Actavis Group, a Switzerland-based generic drugmaker, for up to €5.5bn. Shares in Watson gained 8.8 per cent to $63.69....
...Marc de Garidel, head of Ipsen, the French drug group, says: “Every company is trying to reinforce its own standards....
...Deutsche Bank’s profits dipped more than expected in the first quarter, due to declines in trading income and a €257m hit from the sale of pharmaceutical company Actavis Group hf, Bloomberg reports....
...The action follows the arrests last year in Belgrade of senior officials at the Serbian Institute for Oncology and Radiology, as well as the heads of the Belgrade offices of AstraZeneca, Roche, Actavis,...
...Teva Pharmaceutical Industries of Israel and Iceland’s Actavis Group are also bidding, and Ratiopharm is expected to decide within March....
...The US pharmaceutical group still needs to buy a generic drug-maker. Deutsche still needs to address its loans. Actavis is available, so a deal makes perfect sense for all parties involved....
...In a nail-biting finish to a nine-month auction, Teva beat Pfizer of the US and Actavis of Iceland after offering about €200m more than its rival bidders....
...Actavis, which ranked fifth among the world’s generics groups in 2007, grew rapidly through acquisitions before being taken private by Novator, its leading shareholder, in that year, when it reported sales...
...Deutsche Bank is pursuing a different strategy by pushing Actavis, the Icelandic generic drugmaker that owes the bank €5bn ($6.8bn), to bid for its German rival Ratiopharm in an attempt to recover more of...
...It highlights the continuing fierce competition between generic companies and the originator pharmaceutical groups whose intellectual property they attack, exploiting widely varying patent rules around the...
...Actavis of Iceland has been up for sale, but its €5bn ($7bn) in debt accumulated to finance past acquisitions have discouraged purchasers....
...wealth funds more likely buyers than any of the mainstream pharmaceutical groups....
...Actavis has more than €3bn ($4bn) in debts with Deutsche Bank, which were recently renegotiated....
...But there are also several niche companies in which Sanofi-Aventis may take an interest, including generic drugs companies Actavis and Ratiopharm, and Crucell, the last significant independent vaccine maker...
...Much of the mystery centred around the charismatic figure of Thor Björgólfsson, even now barely 40, Iceland’s richest man and founder of Actavis, the world’s fourth largest maker of generic drugs....
...Two European generic drugs groups – Actavis and Ratiopharm – are also coming up for sale....
...Highlighting this trend, Actavis, the Icelandic generics group, this year acquired Sanmar Speciality Chemicals, based in India, in an attempt to reduce manufacturing costs....
..., who already owns 38.5 per cent of Actavis....
International Edition